Reverie Labs Company

We accelerate preclinical drug development by applying machine learning to lead generation & optimization.


Using recently-developed machine learning techniques, Reverie Labs has developed best-in-class structure-based predictive models for potency and ADME/PK properties of small molecules. Reverie Labs also develops custom models based on its partners' own datasets.

Reverie Labs has developed a multi-objective molecular optimizer that applies evolutionary algorithms to conceive new molecules that optimize for many ADME/PK properties simultaneously while maintaining potency and synthesizability.
Technology: Early And Preclinical Drug Development
Industry: Biomarker Development
Headquarters: USA
Founded Date: 2017

Visit Website
Register and Claim Ownership